Research map: Treatment response to daratumumab in antibody-mediated kidney allograft rejection: evidence from serial protocol biopsies

Back to the article

Papers in this map

  1. Recommended Treatment for Antibody-mediated Rejection After Kidney Transplantation: The 2019 Expert Consensus From the Transplantion Society Working Group · Carrie A. Schinstock · 2019 · 349 citations · Cited by this paper
  2. Patient’s view on: decreasing cardiovascular events after kidney transplantation: a Finnish analysis covering 1990 to 2019 · 2026 · Related
  3. Allorecognition and the spectrum of kidney transplant rejection · Jasper Callemeyn · 2021 · 189 citations · Cited by this paper
  4. Vitamin K and vascular calcification: from biological plausibility to clinical realism · 2026 · Related
  5. Daratumumab in Sensitized Kidney Transplantation: Potentials and Limitations of Experimental and Clinical Use · Jean Kwun · 2019 · 138 citations · Cited by this paper
  6. Trends in the management and coding of chronic kidney disease in Spain: cross-sectional analyses of real-life data with a 5-year interval · 2026 · Related
  7. CD38 Antibody Daratumumab for the Treatment of Chronic Active Antibody-mediated Kidney Allograft Rejection · Konstantin Doberer · 2020 · 124 citations · Cited by this paper
  8. Similar predictive performance and clinical utility of the Kidney Failure Risk Equation using EKFC or CKD-EPI estimated glomerular filtration rate · 2026 · Related
  9. Daratumumab for Treatment of Antibody-Mediated Rejection after ABO-Incompatible Kidney Transplantation · Davide Spica · 2019 · 54 citations · Cited by this paper
  10. Higher cardiovascular risk observed with beta-blockers in CKD patients without prior cardiovascular disease · 2026 · Related
  11. Daratumumab for Antibody-mediated Rejection in Heart Transplant—A Novel Therapy: Successful Treatment of Antibody-mediated Rejection · Cristina Aguilera Agudo · 2021 · 40 citations · Cited by this paper
  12. Changing prognostic significance of peritoneal transport status in contemporary incident peritoneal dialysis patients · 2026 · Related
  13. Daratumumab for antibody-mediated rejection: Is it time to target the real culprit? · Tristan de Nattes · 2023 · 31 citations · Cited by this paper
  14. Association between long-term exposure to particulate matter 2.5 and the risk of rapid renal function decline: a prospective study from CHARLS · 2026 · Related
  15. Microvascular inflammation in kidney allografts: New directions for patient management · Georg A. Böhmig · 2025 · 30 citations · Cited by this paper
  16. Drowning the kidneys: from fluid overload to physiology-guided fluid management in onco-hematology · 2026 · Related
  17. Case report: Daratumumab for treatment of refractory late or chronic active antibody-mediated rejection in renal allograft recipients with high levels of de novo donor-specific antibodies · Lan Zhu · 2023 · 26 citations · Cited by this paper
  18. Improving quality of life in older dialysis patients: the case for broader functional assessment · 2026 · Related
  19. Daratumumab provides transient response of antibody mediated rejection post pediatric orthotopic heart transplantation · Matthew J. Fenton · 2022 · 20 citations · Cited by this paper
  20. A decade of complement inhibition in post-transplant atypical HUS: outcomes with eculizumab and ravulizumab · 2026 · Related
  21. Daratumumab treatment in six highly sensitised solid organ transplant recipients: A case series and literature review · Richard Lemal · 2024 · 18 citations · Cited by this paper
  22. Donor-Derived Cell-Free DNA as a Companion Biomarker for AMR Treatment With Daratumumab: Case Series · Bilgin Osmanodja · 2024 · 18 citations · Cited by this paper
  23. Anti-CD38 Daratumumab Treatment of Chronic Active Antibody-Mediated Kidney Allograft Rejection · Lye Wc · 2025 · 15 citations · Cited by this paper
  24. Daratumumab for Anti‐ HLA Antibody Desensitization and Antibody Mediated Rejection in Pediatric Heart Transplant Patients · Caitlin Milligan · 2025 · 8 citations · Cited by this paper
  25. Searching for the minimum required dose of daratumumab to induce effective plasma cell depletion in antibody-mediated rejection of the kidney graft: a case report · Júlia Ollé · 2024 · 7 citations · Cited by this paper
  26. Daratumumab followed by tocilizumab for treatment of late antibody-mediated rejection in renal transplant recipients with high or moderate levels of de novo donor-specific antibodies: a pilot study · Zhiliang Guo · 2025 · 6 citations · Cited by this paper
  27. Daratumumab for Treatment of Acute Antibody‐Mediated Rejection in a Pediatric Kidney Transplant Recipient · Hailey Connolly · 2025 · 3 citations · Cited by this paper
  28. Successful treatment of refractory donor‐specific‐human leukocyte antigen‐antibody‐induced primary graft‐failure with daratumumab: A case report · Vadim Lesan · 2024 · 1 citation · Cited by this paper
  29. CD38-targeted therapy with Daratumumab in clinical lung transplantation: A single-center experience · Caroline Hillebrand · 2025 · 1 citation · Cited by this paper

Source: OpenAlex (CC0)